Evidence map›Paper›PMID 27427091›Full record

ArticleScientific reports2016

Relational Network for Knowledge Discovery through Heterogeneous Biomedical and Clinical Features.

Huaidong Chen, Wei Chen, Chenglin Liu, Le Zhang, Jing Su, Xiaobo Zhou

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Robust clinical marker identification for diabetic kidney disease with ensemble feature selection.Journal of the American Medical Informatics Association : JAMIA · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Huaidong ChenSchool of Computer and Information Science, Southwest University, Chongqing 400715, China.
Wei ChenCenter for Bioinformatics &Systems Biology, Division of Radiological Sciences, Wake Forest School of Medicine, Winston-Salem, NC, 27127, USA.
Chenglin LiuCenter for Bioinformatics &Systems Biology, Division of Radiological Sciences, Wake Forest School of Medicine, Winston-Salem, NC, 27127, USA.
Le ZhangSchool of Computer and Information Science, Southwest University, Chongqing 400715, China.
Jing SuCenter for Bioinformatics &Systems Biology, Division of Radiological Sciences, Wake Forest School of Medicine, Winston-Salem, NC, 27127, USA.
Xiaobo ZhouCenter for Bioinformatics &Systems Biology, Division of Radiological Sciences, Wake Forest School of Medicine, Winston-Salem, NC, 27127, USA.

Funding

Wake Forest Clinical and Translational Science AwardUL1TR001420 · NCATS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ARD, JAMY D, FOLEY, KRISTIE L · 2015 to 2023
$32.3M
System Biology Approach for Signaling Transduction Study of Complex PhenotypesR01LM010185 · NLM · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ZHOU, XIAOBO, ZU, YOULI · 2009 to 2012
$1.3M
itNETZ: Integrative and Translational Network-based Cellular Signature AnalyzerU01HL111560 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ZHOU, XIAOBO · 2011 to 2013
$1.1M
NCATS NIH HHS UL1 TR001420NHLBI NIH HHS U01 HL111560NLM NIH HHS R01 LM010185
6 · The paper itself

Abstract

Biomedical big data, as a whole, covers numerous features, while each dataset specifically delineates part of them. "Full feature spectrum" knowledge discovery across heterogeneous data sources remains a major challenge. We developed a method called bootstrapping for unified feature association measurement (BUFAM) for pairwise association analysis, and relational dependency network (RDN) modeling for global module detection on features across breast cancer cohorts. Discovered knowledge was cross-validated using data from Wake Forest Baptist Medical Center's electronic medical records and annotated with BioCarta signaling signatures. The clinical potential of the discovered modules was exhibited by stratifying patients for drug responses. A series of discovered associations provided new insights into breast cancer, such as the effects of patient's cultural background on preferences for surgical procedure. We also discovered two groups of highly associated features, the HER2 and the ER modules, each of which described how phenotypes were associated with molecular signatures, diagnostic features, and clinical decisions. The discovered "ER module", which was dominated by cancer immunity, was used as an example for patient stratification and prediction of drug responses to tamoxifen and chemotherapy. BUFAM-derived RDN modeling demonstrated unique ability to discover clinically meaningful and actionable knowledge across highly heterogeneous biomedical big data sets.

Indexed as

AlgorithmsBiomedical TechnologyKnowledgeBreast NeoplasmsFemaleHumansMeta-Analysis as TopicReceptors, EstrogenReceptors, Estrogen

Identifiers

PMID27427091
PMCPMC4947904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.